NIH Offers Mosquito-Fighting Antibodies for Licensing to Combat West Nile
Published Date: 4/22/2026
Notice
Summary
The National Institutes of Health is offering licenses for new antibodies that fight West Nile virus, a serious illness spread by mosquitoes. These antibodies could lead to treatments or preventions, especially for people at high risk. Companies interested in developing these inventions can start licensing now, with some international protections available too.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Licenses Offered for WNV Antibodies
The NIH (NIAID) is offering commercial licenses and collaborative research opportunities for seven new fully human monoclonal antibodies against West Nile virus. Licensing is available now under 35 U.S.C. 209 and 37 CFR part 404, a signed Confidential Disclosure Agreement is required to obtain unpublished information, and HHS Reference No. E-021-2026-0 (Provisional Patent No. 63/991,485 filed February 26, 2026) is listed; contact Brian Bailey at 240-669-5128 or [email protected] for licensing.
Potential Treatments for High-Risk People
Researchers identified antibodies that "could help prevent WNV disease in people at higher risk or treat infection early," noting West Nile virus can cause severe disease especially in older adults and people with weakened immune systems and that there is currently no approved human vaccine or specific antiviral treatment. The antibodies are pre-clinical but are described as candidates for prevention or treatment, individually or in combination.
Antibodies Useful for Diagnostics and Surveillance
The NIH states these high-quality antibodies "may also be useful in laboratory tests for WNV diagnosis, surveillance, and research," and they are available for licensing or collaborative development for such uses. This could support public health testing and monitoring efforts.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09808 — Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
The National Cancer Institute is offering a cool new cancer treatment invention called hetIL-15 that works better when combined with other drugs like Fenofibrate and quizartinib. This combo could help patients by making immune cells stronger and safer, potentially beating tough cancers like breast and pancreatic tumors. Researchers and companies interested in developing or licensing this tech should act soon to join the fight against cancer and bring these treatments to life.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer by turning off some ‘brakes’ inside them. This could lead to stronger treatments for cancer, infections, and autoimmune diseases. Companies interested in developing this technology can license it now, potentially speeding up new, powerful therapies and boosting health outcomes.
2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings protect sensitive info like trade secrets and personal data, so they’re not open to the public. Researchers applying for grants should note these dates as they impact funding decisions and the review process timeline.
2026-08638 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications. These meetings affect researchers seeking funding for brain, behavior, and imaging studies, keeping sensitive info private. No new costs or deadlines are announced, but these reviews shape which projects get money next.
2026-08456 — Proposed Collection; 60-Day Comment Request; NIH Office of Intramural Training & Education-Application, Registration, and Alumni Systems Office of the Director
The NIH Office of Intramural Training & Education wants your thoughts on updating their application, registration, and alumni systems. This affects students, trainees, and alumni who use these systems, aiming to make things smoother and less time-consuming. You’ve got 60 days to share your ideas before they finalize the changes—no extra costs involved, just better tech and less hassle!
2026-08461 — Submission for OMB Review; 30-Day Comment Request Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH is asking for public feedback on a survey about how clinical research training helps healthcare pros in schools and labs. This is a quick 30-day chance to share your thoughts before June 1, 2026. No big costs or changes yet—just making sure the survey is clear and useful for everyone involved.
Previous / Next Documents
Previous: 2026-07769 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special antibodies that fight West Nile Virus—for companies to license and develop into treatments or tests. This means businesses can jump on this opportunity to create medicines or diagnostics, with some foreign patent protections included. Interested parties should act soon and may need to sign a confidentiality agreement to get all the details.
Next: 2026-07771 — Workforce Innovation and Opportunity Act (WIOA) 2026 Lower Living Standard Income Level (LLSIL)
The Department of Labor just updated the 2026 Lower Living Standard Income Level (LLSIL), which helps decide who qualifies as low-income for workforce programs under WIOA. This change affects youth and adults seeking job training and support, making sure the income limits match current poverty guidelines. Starting April 22, 2026, states will use these new numbers to help more people get the skills and jobs they need.